SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Eli Lilly -- Ignore unavailable to you. Want to Upgrade?


To: Mike 2.0 who wrote (496)4/22/1999 9:26:00 AM
From: Platter  Read Replies (1) | Respond to of 642
 
Analysts at EVEREN Securities, Inc. rate LLY an OUTPERFORMER based on the company's recent joint venture with Chugai Pharmaceutical Co. Ltd. to speed the development of its drugs for the Japanese marketplace.